Tele-epilepsy Market size is estimated at USD 474.2 million in 2024 and is set to exceed USD 2.8 billion by the end of 2037, expanding at over 16.2% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of tele-epilepsy is assessed at USD 551.1 million.
The global tele-epilepsy market is expanding due to growing incidences of epilepsy and surging demand for remote management solutions. A 2024 report published by the World Health Organization (WHO) states that around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Almost 80% of epileptics reside in low and middle-income nations.
Moreover, through the utilization of telemedicine technologies, patients have the opportunity to remotely consult with medical professionals such as neurologists and epileptologists, thereby eliminating the necessity for travel and transcending geographical barriers. Enhancing access to care has lead to improved patient outcomes and quality of life, stemming from early diagnosis, timely intervention, and enhanced epilepsy treatment.
Growth Drivers
Challenges
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
16.2% |
Base Year Market Size (2024) |
USD 474.2 million |
Forecast Year Market Size (2037) |
USD 2.8 billion |
Regional Scope |
|
Patient (Adult, Pediatric)
Adult segment is projected to account for more than 57.4% tele-epilepsy market share by the end of 2037. The segment growth can be attributed to the increasing adult population globally. The increasing likelihood of severe complications following a seizure in an adult with epilepsy underscores the importance of tele-epilepsy. Since epilepsy can be caused by strokes, brain tumors, or Alzheimer's disease, the number of new instances of epilepsy starts to rise around the age of 55.
Additionally, the pediatric segment is expected to hold a share of 43.0% during the forecast period. Since children have stronger immune levels and are less susceptible to other diseases, cases of epilepsy in children differ from those in adults in terms of seizure type and epilepsy syndrome. For instance, brain tumors, cysts, and degenerative disorders—conditions that grow and deteriorate over time and are frequently linked to the loss of brain cells—are less frequent causes of epilepsy in children.
Component (Software, Hardware, Service)
By the end of 2037, hardware segment is expected to capture around 42.7% tele-epilepsy market share. The segment growth can be attributed to the widespread use of audio equipment, microphones, videoconferencing technology, and other medical accessories to facilitate virtual visits. Moreover, companies are securing regulatory approvals for new epilepsy treatments, thus expanding the range of options available to patients, making telemedicine platforms more relevant as they integrate new therapies. For instance, leading medical technology company LivaNova PLC also known as LivaNova announced that its Vagus Nerve Stimulation Therapy (VNS Therapy) System, which consists of the SenTiva Generator and next-generation Programming System, has been granted the CE Mark for the treatment of patients with drug-resistant epilepsy (DRE).
End use (Hospital Providers, Payers, Healthcare Consumers)
In tele-epilepsy market, hospital providers segment is predicted to dominate over 37.8% revenue share by 2037. Hospitals are increasingly utilizing telemedicine to connect patients with neurologists and epileptologists, improving access to specialized care, especially in rural areas. Many hospitals are adopting integrated telehealth solutions that combine in-person and virtual care, enhancing patient management and follow-up. Moreover, hospitals are leveraging tele-epilepsy for remote patient monitoring in clinical trials, expanding research opportunities and improving treatment protocols.
Our in-depth analysis of the tele-epilepsy market includes the following segments:
Patient |
|
Component |
|
End use |
|
North America Market Statistics
North America in tele-epilepsy market is projected to hold more than 38.3% revenue share by 2037. The market growth is expected on account of the rising infrastructure technology, the increase in epilepsy cases, and the growth in per capita income. Also, favorable government regulations and the presence of market players are propelling market growth in the region.
The increasing use of telemedicine services and products in the U.S., as well as advantageous government initiatives for epilepsy, are escalating the market growth in the country. According to the Centers for Disease Control and Prevention, in 2022, with age, the percentage of persons using telemedicine rose: among those aged 18 to 29, it was 29.4%; among those over 65, it was 43.3%.
In Canada, the surge in the adoption of smartphones and Internet services is driving the tele-epilepsy market. In 2020, the vast majority of individuals between the ages of 15 and 44 (96%) and 45 and 64 (87%), reported owning a smartphone. Use of wearable devices and mobile applications to track seizures and medication adherence, provide real-time data to healthcare providers.
APAC Market Analysis
Asia Pacific will encounter huge growth for the tele-epilepsy market during the forecast period. The market is expanding due to the widespread use of cutting-edge technology and improved network access. The COVID-19 pandemic accelerated the adoption of telehealth services, with many healthcare providers offering virtual consultations and remote monitoring options.
In China, the increasing prevalence of epilepsy and growing government program offerings are major factors accelerating the market growth. Based on epidemiological surveys, approximately 10 million people in China suffer from epilepsy, with 400,000 to 600,000 new cases being reported each year. In China, epilepsy is still a major health concern, especially in the western provinces.
In India, increased awareness of epilepsy and available treatments among the general public and medical professionals are fueling tele-epilepsy market growth. For instance, every year on November 17, India observes National Epilepsy Day to increase public awareness of the disease and its effects on the individuals, families, and communities it affects.
The burden of lifelong epilepsy in South Korea is expected to rise significantly, in line with global trends, due to the country's aging population. Also, growing adoption of artificial intelligence for EEG analysis, wearable seizure detection devices, and non-invasive brain stimulation methods is boosting the tele-epilepsy market expansion.
Major players in the tele-epilepsy market are increasingly focused on strategic partnerships with technology providers and product development. In addition, they are implementing strategies such as mergers and acquisitions, product and service launches, partnerships, joint ventures, collaborations, and expansions to improve their position in the tele-epilepsy market.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?